Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

When evaluating a subject’s brain structure volumes, looking at absolute volumes is the first step. However, naturally occurring variances due to age or gender might distort the impression these values provide. Differences in overall head size might distort the impression further, and result in questions such as: Is this hippocampus exceptionally small or is my patient’s overall brain size small and the smaller hippocampus is expected for somebody their age?

Normalizing the brain structure to the intracranial volume (ICV) adjusts for differences in overall head size; further restrictions of comparison to male and female subjects of a defined age provides even better results.

Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Using a normative data set established out of large population data gives context to the personalized brain structure volumes over a very broad age range. The WHO and CDC have been using normative reference charts for growth evaluations in children for many years. The same approach is used in the visualization of NeuroQuant®, results displaying an individual’s brain structure volume measurements relative to a healthy population. This allows NeuroQuant to deliver a precise impression of where that individual’s brain structure volume lies within an age- and gender- based reference chart, which aids physicians in their assessment of neurodegenerative conditions.

Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Displaying the normalized patient brain structure volumes with reference to healthy cohorts based on age and gender is an integral part of NeuroQuant and a feature of each NeuroQuant report. Since launch in 2007, the NeuroQuant normative database has been continuously tested and validated against tens of thousands of clinical cases.

Want to learn more about Cortechs.ai Normative Database? Cortechs.ai has developed a Normative Database white paper, which is now available for download.

More Resources

09/03/2025

Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T

Learn how Cat. III CPT codes 0648T and 0649T apply to OnQ™ Prostate, offering guidance for accurate reporting, reimbursement, and building evidence for coverage

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.
Scroll to Top